Dr. Reddy’s Laboratories on Tuesday informed the bourses that its API manufacturing facility at Miryalaguda has received an Establishment Inspection Report (EIR) from the US FDA after the closure of audit.
The stock is trading higher by 1.2% at Rs 2,661.50 per share at 1007 hours IST on BSE. It hit a high of Rs 2,681 and a low of Rs 2,647 during the morning session. The market capitalization of the company is Rs 44,724.48 crore.
The stock has underperformed both BSE Sensex and BSE Healthcare over a period of one year.
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products.
Stock View:
Dr. Reddys Laboratories Ltd is currently trading at Rs 2686.9, up by Rs 58.8 or 2.24% from its previous closing of Rs 2628.1 on the BSE.
The scrip opened at Rs 2678 and has touched a high and low of Rs 2698 and Rs 2647 respectively. So far 441621(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 43570.84 crore.
The BSE group 'A' stock of face value Rs 5 has touched a 52 week high of Rs 3689 on 20-Jul-2016 and a 52 week low of Rs 2382.05 on 29-May-2017. Last one week high and low of the scrip stood at Rs 2664 and Rs 2518.9 respectively.
The promoters holding in the company stood at 26.79 % while Institutions and Non-Institutions held 42.95 % and 30.26 % respectively.
The stock is currently trading above its 200 DMA.
Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide 2 days free trial to our client.Join our services and trade with us.
Get more details here:-
* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
0 comments:
Post a Comment